| 000 | 01451 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250511223623.0 | ||
| 264 | 0 | _c19910715 | |
| 008 | 199107s 0 0 eng d | ||
| 022 | _a0065-2598 | ||
| 024 | 7 |
_a10.1007/978-1-4613-0651-1_15 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFranson, R | |
| 245 | 0 | 0 |
_aInhibition of human phospholipases A2 by cis-unsaturated fatty acids and oligomers of prostaglandin B1. _h[electronic resource] |
| 260 |
_bAdvances in experimental medicine and biology _c1990 |
||
| 300 |
_a219-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aArachidonic Acid |
| 650 | 0 | 4 |
_aArachidonic Acids _xmetabolism |
| 650 | 0 | 4 |
_aFatty Acids, Unsaturated _xpharmacology |
| 650 | 0 | 4 | _aFree Radicals |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMolecular Conformation |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 |
_aPhospholipases A _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPhospholipases A2 |
| 650 | 0 | 4 |
_aProstaglandins B _xchemistry |
| 700 | 1 | _aRaghupathi, R | |
| 700 | 1 | _aFry, M | |
| 700 | 1 | _aSaal, J | |
| 700 | 1 | _aVishwanath, B | |
| 700 | 1 | _aGhosh, S S | |
| 700 | 1 | _aRosenthal, M D | |
| 773 | 0 |
_tAdvances in experimental medicine and biology _gvol. 279 _gp. 219-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/978-1-4613-0651-1_15 _zAvailable from publisher's website |
| 999 |
_c2135145 _d2135145 |
||